Probius

Probius, is a deep-tech company bridging the data gap between biology and AI, thereby illuminating new opportunities for the way biomedical research and healthcare are practiced. By combining physics, mathematics, and biological data, the company will usher in a new age of AI-enabled biological research and decentralized predictive healthcare. Built on ten years of R&D, with over $15M of financial support from the DoD and early-stage investors, the company is commencing the commercialization of its revolutionary products

Nanotechnology,electrochemistry, data science,machine learning,systems biology,life science research,drug discovery & development,biomonitoring, health monitoring,software-defined assays,diagnostics-as-a-service,high-content screening,multi-omics,multiplexed assays,biomarker discovery,disease phenotyping, longitudinal studies, patient stratification,and ultrasensitive quantitative assays

Probius operates in the Biotechnology research industry.

Probius's revenue is 11m - 100m

Probius has 11 - 50 employees.